Metraipolis › archive › dc_ec28bcabbc25

Hepatic arterial infusion chemotherapy (HAlC) versus sorafenib for hepatocellular carcinoma (HCC) in Barcelona Clinic Liver Cancer (BCLC) B/C: A systematic… — Europe PMC PMID:41706717

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41706717
DOI: 10.1371/journal.pone.0342495
License (as archived): solo-consultazione
Archived: 2026-11-05T16:42:01.447Z
SHA-256 of the archived text: 26b599559bb5ecefad56275f45dd2244122429ba36734af416aa01ea84b48582
Stable URL of this page: https://metraipolis.com/documento/dc_ec28bcabbc25

How to cite

Hepatic arterial infusion chemotherapy (HAlC) versus sorafenib for hepatocellular carcinoma (HCC) in Barcelona Clinic Liver Cancer (BCLC) B/C: A systematic… — Europe PMC PMID:41706717 — Europe PMC (en), https://europepmc.org/article/MED/41706717 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ec28bcabbc25 (Metraipolis archive dc_ec28bcabbc25, sha256 26b599559bb5ecefad56275f45dd2244122429ba36734af416aa01ea84b48582)

BibTeX

@misc{dcec28bcabbc25,
  title = {Hepatic arterial infusion chemotherapy (HAlC) versus sorafenib for hepatocellular carcinoma (HCC) in Barcelona Clinic Liver Cancer (BCLC) B/C: A systematic… — Europe PMC PMID:41706717},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41706717},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ec28bcabbc25; sha256 26b599559bb5ecefad56275f45dd2244122429ba36734af416aa01ea84b48582},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41706717. Agents can read the archived copy with the MCP tool read_document.